Tema Cardiovascular and Metabolics ETF (HRTS) Holdings $30.72 -0.02 (-0.07%) As of 02/21/2025 03:34 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrends Top 46 HRTS HoldingsRankCompanyCurrent PriceWeightShares Held1LLYEli Lilly and Company$874.12+0.1%10.12%8,0562UNHUnitedHealth Group$465.58-7.3%6.00%7,8373AstraZeneca PLCN/A4.13%19,0974BBIOBridgeBio Pharma$36.85+0.1%3.91%85,9425RHHBYRoche$41.42+0.7%3.75%63,0386ABTAbbott Laboratories$135.04+1.4%3.72%19,5707Novo Nordisk A/SN/A3.69%32,3008VRTXVertex Pharmaceuticals$484.24+0.8%3.56%5,3419Chugai Pharmaceutical Co., Ltd.N/A3.31%48,38110MRKMerck & Co., Inc.$89.40+2.0%3.15%25,876 Get the Latest News and Ratings for HRTS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Cardiovascular and Metabolics ETF and its competitors with MarketBeat's FREE daily newsletter. 11BSXBoston Scientific$104.44-0.9%3.12%20,40612TMOThermo Fisher Scientific$532.55-1.0%2.88%3,74813Novartis AGN/A2.76%17,66614MDTMedtronic$89.95+2.3%2.72%20,47015AMGNAmgen$303.01+1.7%2.65%6,18716GILDGilead Sciences$109.95-0.1%2.61%17,12017ABBVAbbVie$202.03+0.6%2.41%8,63718CRNXCrinetics Pharmaceuticals$37.48+1.7%2.07%40,75119EWEdwards Lifesciences$73.25-2.0%2.03%18,54320DHRDanaher$209.86+0.9%1.96%6,68921MASIMasimo$169.96-4.1%1.94%7,51122PODDInsulet$282.80-1.9%1.93%4,74023ALNYAlnylam Pharmaceuticals$250.59-0.2%1.92%5,01824BMYBristol-Myers Squibb$55.85+0.1%1.86%23,01325REGNRegeneron Pharmaceuticals$700.33+0.6%1.84%1,89626CYTKCytokinetics$50.26-1.7%1.71%28,49427MCKMcKesson$597.68-1.0%1.52%1,74928DXCMDexCom$88.78-0.6%1.47%12,09829ASNDAscendis Pharma A/S$152.43-1.4%1.40%6,83130Zealand Pharma A/SN/A1.33%8,77631MDGLMadrigal Pharmaceuticals$336.23-4.2%1.29%2,55332MREOMereo BioPharma Group$2.86-0.5%1.19%286,10433Gubra A/SN/A0.96%7,05034RCKTRocket Pharmaceuticals$10.47-3.7%0.96%66,07335AKROAkero Therapeutics$51.84+2.5%0.94%13,20336MIRMMirum Pharmaceuticals$52.50-1.2%0.94%12,80737ARWRArrowhead Pharmaceuticals$19.90-5.1%0.92%33,51838INSMInsmed$81.06-3.0%0.91%7,98639GPCRStructure Therapeutics$23.70+1.3%0.89%25,34040IONSIonis Pharmaceuticals$32.33-1.1%0.82%18,858Trump doesn’t give a damn (Ad)Porter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met with one of Trump’s longest-serving advisors. We helped put together a plan to help investors capitalize on Trump’s election. And we found out these 10 stocks are the most likely to boom…Go here now to find out the names of these 10 stocks.41First American Treasury Obligations FundN/A0.75%522,05542WSTWest Pharmaceutical Services$210.72+3.5%0.73%2,52943VKTXViking Therapeutics$34.07+7.7%0.65%15,37044NTLAIntellia Therapeutics$12.17-0.7%0.49%35,34445DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A0.06%373,357,13446US DOLLARSN/A0.06%38,895 Geographic ExposureUnited States81.1%Denmark5.4%United Kingdom4.0%Japan3.4%Switzerland2.7%Ireland2.5%Currency ExposureUSD83.6%DKK6.3%GBP4.0%JPY3.4%CHF2.7%Sector ExposureHealth Care86.5%Industry ExposureBiotechnology54.6%Health Care Equipment & Supplies22.1%Health Care Providers & Services5.6%Pharmaceuticals2.7%Health Care Technology1.5%SubIndustry ExposureBiotechnology49.8%Health Care Equipment12.9%Life Sciences Tools & Services8.5%Pharmaceuticals6.3%Managed Health Care5.6%Health Care Distributors1.5%Health Care Supplies0.7%Coupon Exposure4-60.8%Maturity Exposure15-200.8% Related Companies and Tools Related Companies Fidelity Disruptive Communications ETF Portfolio Companies Tema Oncology ETF Portfolio Companies YieldMax Crypto Industry and Tech Portfolio Option Income ETF Portfolio Companies Global X Genomics & Biotechnology ETF Portfolio Companies Tradr 2X Long Innovation ETF Portfolio Companies VictoryShares THB Mid Cap ESG ETF Portfolio Companies Invesco ESG NASDAQ 100 ETF Portfolio Companies Procure Space ETF Portfolio Companies Global X U.S. Electrification ETF Portfolio Companies Global X Data Center & Digital Infrastructure ETF Portfolio Companies This page (NASDAQ:HRTS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Cardiovascular and Metabolics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HRTS Stock Alerts